{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:29:00Z","timestamp":1772785740276,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA046576"],"award-info":[{"award-number":["R01 DA046576"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA168524"],"award-info":[{"award-number":["P30 CA168524"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000001"],"award-info":[{"award-number":["UL1TR000001"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.conctc.2022.101032","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T06:01:13Z","timestamp":1667628073000},"page":"101032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Protocol from a randomized clinical trial of multiple pharmacotherapy adaptations based on treatment response in African Americans who smoke"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-0061","authenticated-orcid":false,"given":"Nicole L.","family":"Nollen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa Sanderson","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward F.","family":"Ellerbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Salzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denton","family":"Shanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Allen","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasjit S.","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2022.101032_bib1","series-title":"The Health Consequences of Smoking--50 Years of Progress","year":"2014"},{"key":"10.1016\/j.conctc.2022.101032_bib2","series-title":"Cancer Facts & Figures for African Americans 2013-2014","year":"2013"},{"key":"10.1016\/j.conctc.2022.101032_bib3","series-title":"Treating Tobacco Use and Dependence Clinical Practice Guideline: 2008 Update","author":"Fiore","year":"2008"},{"issue":"52","key":"10.1016\/j.conctc.2022.101032_bib4","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.15585\/mmwr.mm6552a1","article-title":"Quitting smoking among adults - United States, 2000-2015","volume":"65","author":"Babb","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"5","key":"10.1016\/j.conctc.2022.101032_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (jnc 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"Supplement 1","key":"10.1016\/j.conctc.2022.101032_bib6","first-page":"S64","article-title":"8. Pharmacologic approaches to glycemic treatment","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.conctc.2022.101032_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/add.13161","article-title":"Comparative effectiveness of motivation phase intervention components for use with smokers unwilling to quit: a factorial screening experiment","volume":"111","author":"Cook","year":"2016","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.conctc.2022.101032_bib8","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.amepre.2017.01.038","article-title":"Effectiveness of switching smoking-cessation medications following relapse","volume":"53","author":"Heckman","year":"2017","journal-title":"Am. J. Prev. Med."},{"issue":"1","key":"10.1016\/j.conctc.2022.101032_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/add.13162","article-title":"Identifying effective intervention components for smoking cessation: a factorial screening experiment","volume":"111","author":"Piper","year":"2016","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.conctc.2022.101032_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1176\/appi.ajp.2013.12070919","article-title":"Adapting smoking cessation treatment according to initial response to precessation nicotine patch","volume":"170","author":"Rose","year":"2013","journal-title":"Am. J. Psychiatr."},{"issue":"11","key":"10.1016\/j.conctc.2022.101032_bib11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1176\/appi.ajp.2014.13050595","article-title":"Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm","volume":"171","author":"Rose","year":"2014","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.conctc.2022.101032_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/add.13153","article-title":"Comparative effectiveness of intervention components for producing long-term abstinence from smoking: a factorial screening experiment","volume":"111","author":"Schlam","year":"2016","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.conctc.2022.101032_bib13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1360-0443.2006.01461.x","article-title":"The effects of nicotine gum and counseling among African American light smokers: a 2 x 2 factorial design","volume":"101","author":"Ahluwalia","year":"2006","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.conctc.2022.101032_bib14","first-page":"A78","article-title":"Adult tobacco use among racial and ethnic groups living in the United States, 2002-2005","volume":"5","author":"Caraballo","year":"2008","journal-title":"Prev. Chronic Dis."},{"issue":"2","key":"10.1016\/j.conctc.2022.101032_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/jama.280.2.135","article-title":"Racial and ethnic differences in serum cotinine levels of cigarette smokers: third National Health and Nutrition Examination Survey, 1988-1991","volume":"280","author":"Caraballo","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.conctc.2022.101032_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jnci\/djr513","article-title":"Bupropion for smoking cessation in African American light smokers: a randomized controlled trial","volume":"104","author":"Cox","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.conctc.2022.101032_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.5993\/AJHB.36.5.4","article-title":"African American smokers' intention to use pharmacotherapy for cessation","volume":"36","author":"Lynam","year":"2012","journal-title":"Am. J. Health Behav."},{"key":"10.1016\/j.conctc.2022.101032_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cct.2015.12.001","article-title":"A clinical trial to examine disparities in quitting between African-American and White adult smokers: design, accrual, and baseline characteristics","volume":"47","author":"Nollen","year":"2016","journal-title":"Contemp. Clin. Trials"},{"issue":"9","key":"10.1016\/j.conctc.2022.101032_bib19","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.clinthera.2009.08.029","article-title":"Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers","volume":"31","author":"Ferguson","year":"2009","journal-title":"Clin. Therapeut."},{"issue":"5","key":"10.1016\/j.conctc.2022.101032_bib20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0149-2918(01)80023-0","article-title":"Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo","volume":"23","author":"Jamerson","year":"2001","journal-title":"Clin. Therapeut."},{"issue":"8","key":"10.1016\/j.conctc.2022.101032_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jama.1994.03510320029025","article-title":"Predicting smoking cessation. Who will quit with and without the nicotine patch","volume":"271","author":"Kenford","year":"1994","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.conctc.2022.101032_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ntr\/ntn018","article-title":"Intermittent and light daily smoking across racial\/ethnic groups in the United States","volume":"11","author":"Trinidad","year":"2009","journal-title":"Nicotine Tob. Res."},{"issue":"4","key":"10.1016\/j.conctc.2022.101032_bib23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/jama.288.4.468","article-title":"Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial","volume":"288","author":"Ahluwalia","year":"2002","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.conctc.2022.101032_bib24","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/add.14948","article-title":"Counseling alone or in combination with nicotine replacement therapy for treatment of black non-daily smokers: a randomized trial","volume":"115","author":"Nollen","year":"2020","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.conctc.2022.101032_bib25","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/jnci\/djz001","article-title":"Factors that explain differences in abstinence between black and white smokers: a prospective intervention study","volume":"111","author":"Nollen","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.conctc.2022.101032_bib26","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ntr\/ntab040","article-title":"Patterns of non-cigarette tobacco and nicotine use among current cigarette smokers and recent quitters: findings from the 2020 ITC four country smoking and vaping survey","volume":"23","author":"Li","year":"2021","journal-title":"Nicotine Tob. Res."},{"issue":"1","key":"10.1016\/j.conctc.2022.101032_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.32053","article-title":"Assessment of racial differences in pharmacotherapy efficacy for smoking cessation: secondary analysis of the EAGLES randomized clinical trial","volume":"4","author":"Nollen","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"9","key":"10.1016\/j.conctc.2022.101032_bib28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.conctc.2022.101032_bib29","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/add.13806","article-title":"Extended treatment for cigarette smoking cessation: a randomized control trial","volume":"112","author":"Laude","year":"2017","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.conctc.2022.101032_bib30","first-page":"1668","article-title":"Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy","volume":"11","author":"Jacob","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"9","key":"10.1016\/j.conctc.2022.101032_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.conctc.2022.101032_bib32","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.1360-0443.2011.03441.x","article-title":"Relative performance of common biochemical indicators in detecting cigarette smoking","volume":"106","author":"Marrone","year":"2011","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.conctc.2022.101032_bib33","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/BCR.0b013e318264bf7d","article-title":"Objective color measurements: clinimetric performance of three devices on normal skin and scar tissue","volume":"34","author":"van der Wal","year":"2013","journal-title":"J. Burn Care Res."},{"issue":"4","key":"10.1016\/j.conctc.2022.101032_bib34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2105\/AJPH.2009.172676","article-title":"Financial strain and smoking cessation among racially\/ethnically diverse smokers","volume":"100","author":"Kendzor","year":"2010","journal-title":"Am. J. Publ. Health"},{"issue":"9","key":"10.1016\/j.conctc.2022.101032_bib35","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/aje\/152.9.874","article-title":"Survival, functional limitations, and self-rated health in the NHANES I epidemiologic follow-up study, 1992. First national health and nutrition examination survey","volume":"152","author":"Idler","year":"2000","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.conctc.2022.101032_bib36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1037\/a0015270","article-title":"Timeline follow-back versus global self-reports of tobacco smoking: a comparison of findings with nondaily smokers","volume":"23","author":"Harris","year":"2009","journal-title":"Psychol. Addict. Behav."},{"issue":"2","key":"10.1016\/j.conctc.2022.101032_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/0893-164X.12.2.101","article-title":"I.W. Reliability and validity of a smoking timeline follow-back interview","volume":"12","author":"Brown","year":"1998","journal-title":"Psychol. Addict. Behav."},{"issue":"12","key":"10.1016\/j.conctc.2022.101032_bib38","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/ntr\/nts018","article-title":"The Fagerstrom Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data","volume":"14","author":"Fagerstrom","year":"2012","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.conctc.2022.101032_bib39","series-title":"National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey","year":"2012"},{"key":"10.1016\/j.conctc.2022.101032_bib40","series-title":"National Survey on Drug Use and Health: Detailed Tables","author":"Center for Behavioral Health Statistics and Quality","year":"2014"},{"issue":"4","key":"10.1016\/j.conctc.2022.101032_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J. Health Soc. Behav."},{"key":"10.1016\/j.conctc.2022.101032_bib42","series-title":"The Social Psychology of Health","first-page":"31","article-title":"Perceived stress in a probability sample of the United States","author":"Cohen","year":"1988"},{"issue":"1","key":"10.1016\/j.conctc.2022.101032_bib43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S1742058X11000087","article-title":"Racial disparities in health","volume":"8","author":"Sternthal","year":"2011","journal-title":"Du. Bois Rev.: Social Science Research on Race"},{"issue":"7","key":"10.1016\/j.conctc.2022.101032_bib44","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/ntr\/ntr285","article-title":"Neighborhood perceptions are associated with tobacco dependence among African American smokers","volume":"14","author":"Reitzel","year":"2012","journal-title":"Nicotine Tob. Res."},{"issue":"3","key":"10.1016\/j.conctc.2022.101032_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1207\/S15324796ABM2303_5","article-title":"Neighborhood problems as sources of chronic stress: development of a measure of neighborhood problems, and associations with socioeconomic status and health","volume":"23","author":"Steptoe","year":"2001","journal-title":"Ann. Behav. Med."},{"issue":"2","key":"10.1016\/j.conctc.2022.101032_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1207\/s15324796abm2702_3","article-title":"How neighborhoods and physical functioning are related: the roles of neighborhood socioeconomic status, perceived neighborhood strain, and individual health risk factors","volume":"27","author":"Feldman","year":"2004","journal-title":"Ann. Behav. Med."},{"key":"10.1016\/j.conctc.2022.101032_bib47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1749-6632.1999.tb08117.x","article-title":"Psychosocial resources and the SES-health relationship","volume":"896","author":"Taylor","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.conctc.2022.101032_bib48","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2105\/AJPH.2019.305383","article-title":"Driver's license suspension policies as a barrier to health care","volume":"109","author":"Joyce","year":"2019","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.conctc.2022.101032_bib49","series-title":"Inter-university Consortium for Political and Social Research [distributor]","article-title":"The survey of criminal justice experience (SCJE), 2013","author":"Brown","year":"2014"},{"key":"10.1016\/j.conctc.2022.101032_bib50","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/10705500802222972","article-title":"The brief resilience scale: assessing the ability to bounce back","volume":"15","author":"Smith","year":"2008","journal-title":"Int. J. Behav. Med."},{"issue":"11","key":"10.1016\/j.conctc.2022.101032_bib51","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med. Care"},{"issue":"10","key":"10.1016\/j.conctc.2022.101032_bib52","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.conctc.2022.101032_bib53","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.amepre.2019.04.001","article-title":"Relationship of childhood Abuse and household dysfunction to many of the leading causes of death in adults: the adverse childhood experiences (ACE) study","volume":"56","author":"Felitti","year":"2019","journal-title":"Am. J. Prev. Med."},{"issue":"3","key":"10.1016\/j.conctc.2022.101032_bib54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14622200701188919","article-title":"Effects of abstinence from tobacco: valid symptoms and time course","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.conctc.2022.101032_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06298.x","article-title":"The clinical significance of drug craving","volume":"1248","author":"Tiffany","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.conctc.2022.101032_bib56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.conctc.2022.101032_bib57","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/ntr\/ntr063","article-title":"A pilot clinical trial of varenicline for smoking cessation in black smokers","volume":"13","author":"Nollen","year":"2011","journal-title":"Nicotine Tob. Res."},{"issue":"1","key":"10.1016\/j.conctc.2022.101032_bib58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pbb.2008.10.016","article-title":"Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study","volume":"92","author":"Schnoll","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.conctc.2022.101032_bib59","doi-asserted-by":"crossref","first-page":"144","DOI":"10.7326\/0003-4819-152-3-201002020-00005","article-title":"Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial","volume":"152","author":"Schnoll","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.conctc.2022.101032_bib60","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addbeh.2014.11.012","article-title":"Smoking cessation abstinence goal in treatment-seeking smokers","volume":"42","author":"Hall","year":"2015","journal-title":"Addict. Behav."},{"issue":"10","key":"10.1016\/j.conctc.2022.101032_bib61","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/abm\/kax059","article-title":"A randomized controlled trial of an optimized smoking treatment delivered in primary care","volume":"52","author":"Piper","year":"2018","journal-title":"Ann. Behav. Med."},{"issue":"1","key":"10.1016\/j.conctc.2022.101032_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1525-1497.1998.00001.x","article-title":"Smoking cessation among inner-city African Americans using the nicotine transdermal patch","volume":"13","author":"Ahluwalia","year":"1998","journal-title":"J. Gen. Intern. Med."},{"issue":"3","key":"10.1016\/j.conctc.2022.101032_bib63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jsat.2009.01.006","article-title":"Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking","volume":"37","author":"Gariti","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"issue":"2","key":"10.1016\/j.conctc.2022.101032_bib64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(14)70294-2","article-title":"A randomized placebo-controlled trial to test a genetically-informed biomarker ForPersonalizing treatment for tobacco dependence","volume":"3","author":"Lerman","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.conctc.2022.101032_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14622200210123581","article-title":"Biochemical verification of tobacco use and cessation","volume":"4","author":"Benowitz","year":"2002","journal-title":"Nicotine Tob. Res."},{"issue":"1","key":"10.1016\/j.conctc.2022.101032_bib66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/tc.2008.025981","article-title":"Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding","volume":"18","author":"Kotz","year":"2009","journal-title":"Tobac. Control"},{"issue":"6","key":"10.1016\/j.conctc.2022.101032_bib67","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ntr\/ntq067","article-title":"Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials","volume":"12","author":"Piper","year":"2010","journal-title":"Nicotine Tob. Res."},{"issue":"3","key":"10.1016\/j.conctc.2022.101032_bib68","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1360-0443.2004.00995.x","article-title":"Outcome criteria in smoking cessation trials: proposal for a common standard","volume":"100","author":"West","year":"2005","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.conctc.2022.101032_bib69","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","article-title":"The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations","volume":"51","author":"Baron","year":"1986","journal-title":"J. Pers. Soc. Psychol."},{"key":"10.1016\/j.conctc.2022.101032_bib70","first-page":"343","article-title":"CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials","year":"2011","journal-title":"BMJ"},{"issue":"46","key":"10.1016\/j.conctc.2022.101032_bib71","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.15585\/mmwr.mm6946a4","article-title":"Tobacco product use among adults - United States, 2019","volume":"69","author":"Cornelius","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.conctc.2022.101032_bib72","series-title":"Cancer Facts & Figures for African Americans, 2017-2019","year":"2020"},{"issue":"17","key":"10.1016\/j.conctc.2022.101032_bib73","doi-asserted-by":"crossref","first-page":"444","DOI":"10.15585\/mmwr.mm6617e1","article-title":"Vital signs: racial disparities in age-specific mortality among blacks or african Americans - United States, 1999-2015","volume":"66","author":"Cunningham","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"4","key":"10.1016\/j.conctc.2022.101032_bib74","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa033250","article-title":"Ethnic and racial differences in the smoking-related risk of lung cancer","volume":"354","author":"Haiman","year":"2006","journal-title":"N. Engl. J. Med."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865422001491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865422001491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:10:49Z","timestamp":1762521049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865422001491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":74,"alternative-id":["S2451865422001491"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2022.101032","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol from a randomized clinical trial of multiple pharmacotherapy adaptations based on treatment response in African Americans who smoke","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2022.101032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101032"}}